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Abstract: Development of novel bioimaging materials that exhibit 
organelle specific accumulation continues to be at the forefront of 
research interests and efforts. Among the various subcellular 
organelles, mitochondria, which are found in the cytoplasm of 
eukaryotic cells, are of particular interest in relation to their vital 
function. To date, most molecular probes that target mitochondria 
utilise delocalised lipophilic cations such as triphenylphosphonium 
and pyridinium. However, the use of such charged motifs is known to 
be detrimental to the working function of the mitochondrial 
transmembrane potential and there remains a strong case for 
development of neutral mitochondrial fluorescent probes. Herein, we 
demonstrate for the first time the exploitation of diketopyrrolopyrrole-
based chemistries for the realisation of a neutral fluorescent probe 
that exhibits organelle specific accumulation within the mitochondria 
at the nanomolar level. The synthesised probe, which bears a neutral 
triphenylphosphine oxide moiety, exhibits a large Stokes shift and 
high fluorescence quantum yield in water, both highly sought-after 
properties in the development of bioimaging agents. In-vitro studies 
reveal no interference with cell metabolism when tested for the human 
MCF7 breast cancer cell and nanomolar subcellular organelle 
colocalisation with commercially available mitochondrial staining 
agent Mitotracker Red.  In light of its novelty, neutral structure and the 
preferential accumulation at nanomolar concentrations we anticipate 
this work to be of significant interest for the increasingly larger 
community devoted to the realisation of neutral mitochondrial 
selective systems and more widely to those engaged in the rational 
development of superior organic architectures in the biological field. 
Introduction 
Over the last two decades there has been increasing interest in 
the rational development of novel bioimaging materials which 
exhibit organelle specific accumulation.[1–8] Among those 
subcellular organelles of interest, mitochondria, which are found 
in the cytoplasm of eukaryotic cells, are of particular note and 
significant efforts have been devoted towards the realisation of 
novel staining agents.[5–8] Mitochondria denote the principal 
energy-producing compartment in most eukaryotes. Their 
function is critical in a number of vital process such as adenosine 
triphosphate (ATP) production, central metabolism and 
apoptosis,[9,10] and irregularities in these functions are intimately 
linked to degenerative diseases such as Alzheimer’s and 
Parkinson’s as well as cardiac complications and cancer.[6–10] 
Currently, a range of diagnostic imaging techniques, such as 
radioisotope labelling, magnetic resonance imaging and positron 
emission tomography, are employed for monitoring subcellular 
organelles.[6,11] Recently, approaches exploiting fluorescence 
emission have been developed for the investigation of specific 
organelles such as mitochondria, representing a powerful class of 
imaging strategies, on account of their ability to translate 
molecular recognition into highly discriminative and easily 
detected optical signals.[6,12,13] 
The mitochondrion, which is structurally characterised by a 
double membrane separated by the intermembrane space, 
exhibits a highly negative transmembrane potential as a result of 
the process of mitochondrial respiration whereby the proton 
pumps in the inner mitochondrial membrane transport protons 
onto the intermembrane space.[11,14–17] This large potential 
distinguishes it from other subcellular organelles and has inspired 
the successful development of optically active probes that exploit 
it selectively. Thus, systems containing delocalised lipophilic 
cations (DLCs) such as triphenylphosphonium or pyridinium 
cation, which are present in the majority of mitochondria targeting 
probes to date and which are believed to improve membrane 
transport and increase mitochondria probe accumulation, have 
been widely used to ensure selectivity towards this subcellular 
compartment attracted by the negative potential of the membrane, 
whilst maintaining an otherwise non-polar framework in most 
cases.[6–8,18] In this regard, a number of organic dyes such as 
fluorescein,[19,20] coumarin[21,22] and rhodamine[23,24] have been 
utilised, as the fluorescent tag to which DLCs are anchored. 
However, their biological applications are often limited by their 
photophysical and/or biological properties. Importantly, and 
despite the large efforts devoted to the development of charged 
fluorescent probes as selective staining agents for mitochondria, 
the known negative effects of cationic systems are often 
overlooked. In short, these lipophilic cationic structures carry the 
risk of reducing the mitochondria membrane potential (MMP), 
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which is associated to detrimental effects in their critical working 
function. Further, probe leakage through the membrane can also 
be attributed to a reduction in the MMP, hence decreasing the 
efficiency of the staining agents.[7,18] In response to the latter, the 
development of neutral fluorescent probes that maintain selective 
targeting of mitochondria and alleviate those concerns would 
represent major innovations and is therefore highly warranted.[25] 
Whilst access to the mitochondria intermembrane space is 
relatively straightforward, facilitated by means of large protein-
based pores in the outer membrane, the inner membrane is 
characterised by a much more restricted permeability, loaded with 
proteins that play a role in electron transport and ATP synthesis 
processes. Transport across and onto the mitochondrial matrix 
can only occur aided by specific membrane transport 
proteins.[14,18] The latter has motivated the development of 
peptide-based mitochondrion staining agents whereby specific 
protein-ligand type interactions are favoured, which could foster 
the rational development of novel non-peptidic alternatives for 
mitochondrial staining species.[8,18]   
In response to these findings and motivated by the latter, we are 
engaged in the development of novel non-charged systems that 
can exhibit selective organelle accumulation exploiting 
diketopyrrolopyrrole (DPP) chemistries. DPPs were first 
employed in industry as high performance pigments on account 
of their desirable properties such as brightness as well as light 
and weather fastness and then widely used as charge transfer 
mediating materials in optoelectronic applications.[26–30] Despite 
the promising performance of some DPP-based materials in the 
bioimaging field, their utilisation as mitochondria specific staining 
agents is still underexploited and fully relies on the use of charged 
moieties.[31–35] In addition, the realisation of DPP-based staining 
agents at the nanomolar level still represents a challenge in the 
field. Herein, we report the rational development, in-depth 
photophysical analysis and in-vitro imaging of a novel neutral 
DPP-based selective mitochondrial staining agent (PhODPP) at 
the nanomolar level. To design the probe, we initially explored the 
ability of a DPP material bearing a non-charged 
triphenylphosphine group (PhDPP) to exhibit preferential 
subcellular organelle accumulation for mitochondria, based on 
previous reports exploiting triphenylphosphonium cation. We 
observed that whilst cell viability studies for PhDPP were 
consistent with no interference of the probe with the cell 
metabolism, it exhibited relatively low cell uptake at commonly 
employed concentrations, which could be partially ascribed to its 
low fluorescence quantum yield and accumulation in subcellular 
organelles other than mitochondria. Employing in-silico design, 
we formulated a superior alternative whereby chemical oxidation 
of the phosphine to phosphine oxide precludes 
thermodynamically favoured photoinduced electron transfer 
(PET) exhibited by PhDPP, resulting in a remarkable 7-fold 
increase in the fluorescence quantum yield in water. Importantly, 
the oxidised probe was also characterised by no interference with 
cell metabolism when tested for the human MCF7 breast cancer 
cell and to exhibit larger cell uptake and nanomolar organelle 
accumulation within the mitochondria, which, in the absence of a 
charged motif, we attribute to a reversal of the non-covalent 
interactions of the triphenylphosphine oxide unit with protein 
binding pockets within the inner mitochondrial membrane. As 
such, our oxidised probe denotes the first non-charged DPP 
based system for selective imaging of this subcellular organelle 
reported to date. In addition, it represents the first DPP-based 
bioimaging probe with sensitivity at the nanomolar level and 
comparable performance to the commercially available 
Mitotracker Red staining agent. The latter, associated to its 
neutral characteristics makes this probe a major innovation in the 
field. 
Results and Discussion 
Synthesis, photophysical properties and subcellular 
accumulation of PhDPP 
Inspired by the large number of reported probes exhibiting 
selective mitochondria accumulation by exploiting the 
triphenylphosphonium moiety and our desire to develop non-
charged fluorophores that exhibit preferential subcellular 
accumulation for this organelle, we initially synthesised an 
asymmetric model DPP bearing a non-cationic 
triphenylphosphine unit anchored to one of the core phenyl rings 
(Scheme 1). Although most efforts devoted to the realisation of 
mitochondrial staining agents are based around the utilisation of 
charged moieties such as triphenylphosphonium or pyridinium 
cations, we wanted to explore whether a neutral 
triphenylphosphine substitution would facilitate probe 
accumulation within the mitochondria. Synthesis of the model 
DPP phosphine derivative, PhDPP was carried out via an 
optimised palladium catalysed phosphination[36] of a mono-
iodinated DPP[37] using Pd(OAc)2 as shown in Scheme 1 (SI.1 
ESI†). Phosphination of the mono-brominated DPP or the use of 
Pd(PPh3)4 as catalyst gave lower yields of the target compound. 
Alternatively, conventional organolithium and Grignard mediated 
phosphination reactions of the mono-iodinated and mono-
brominated DPP were explored, however neither approach gave 
any conversion to the corresponding phosphine derivative.  
Scheme 1. Synthesis of PhDPP. a) 4-iodobenzonitrile, Na, t-amyl alcohol, 
reflux; b) BnBr, DMF, K2CO3, 120 °C; c) PPh3, Pd(OAc)2, DMF, 120 °C. 
The absorption and fluorescence emission properties of PhDPP 
were experimentally determined in solution in the solvents of 
acetonitrile, dichloromethane, dimethyl sulfoxide (DMSO) and 
water (0.2% DMSO as co-solvent). Figure 1 illustrates the 
normalised absorption and fluorescence emission spectra for this 
probe in the investigated solvents. In all cases, absorption spectra 
for the probe were broad, displaying no vibronic structure and a 
small bathochromic shift on progression to water. Fluorescence 
emission spectra displayed vibronic progression and spectral 
shape irrespective of the excitation wavelength (SI.2 ESI†), with 
the intensity of the 0-0 band being greater than that of the 0-1 
band in all cases but water, thus consistent with relatively small 
structural changes on progression to excited state geometries. In 
turn, the fluorescence emission spectrum of PhDPP in water 
illustrates a reversal of the relative intensities of the first and 
second vibrational bands and an associated bathochromic shift 
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(λem = 549 and 604 nm in DMSO and water, respectively) and 
larger Stokes shift when compared to the spectra in other solvents 
(Δλmax = 2749 and 4233 cm-1 in DMSO and water, respectively). 
The latter denotes a highly desirable property as to diminish the 
probability of self-absorption that could compromise the potential 
application of the probe as a bioimaging agent. 
Figure 1. Normalised absorption (solid line) and fluorescence emission (dashed 
line) spectra of PhDPP in acetonitrile (red), dichloromethane (yellow), DMSO 
(blue) and water (0.2% DMSO, green). 
Underpinned by a detailed understanding of the photophysical 
properties of PhDPP (see Table 1 for details), we sought to test 
its cell viability and ability to exhibit preferential subcellular 
organelle accumulation. Firstly, the cell viability of the 
triphenylphosphine bearing DPP was determined for the human 
cell MCF7 breast cancer cells by the resazurin based metabolic 
assay PrestoBlue. Cells were treated with PhDPP at 
concentrations ranging from 0.2 – 21.4 µg/mL (0.31 – 33 µM) and 
incubated for 1h. In all cases we observed viabilities higher than 
90%, thus indicating no interference with the cell metabolism 
(Figure 6A). Subsequently, we went on to explore the intracellular 
uptake and localisation of PhDPP. We observed that at a typical 
concentration previously utilised for bioimaging probes (1µg/mL = 
1.5 µM), the cellular uptake is relatively low (SI.3 ESI†). Co-
localisation of the developed probe with commercially available 
mitochondrial staining agent Mitotracker Red CMXRos (250 nM), 
revealed that PhDPP does not preferentially accumulate within 
the mitochondria (SI.3 ESI†). Via analysis of the photophysical 
properties of PhDPP and the subcellular localisation data, we 
ascribe the aforementioned findings to: i) the inability of the 
neutral triphenylphosphine moiety in fostering strong binding 
interactions with appropriate proteins within the inner 
mitochondrial membrane, and ii) to a lesser extent the low 
fluorescence quantum yield (Φf = 0.08±0.02 in water) that could 




Rational development, synthesis and photophysical 
properties of PhODPP 
Next, we engaged in the rational development of a potentially 
superior, whilst structurally related, probe whereby fluorescence 
efficiency as well as cell uptake and mitochondrial accumulation 
could be improved. First, we proposed via analysis of PhDPP 
structure, that the low experimentally determined fluorescence 
quantum yield could occur as a result of a thermodynamically 
favoured intramolecular PET from the lone pair of electrons in the 
phosphine within the triphenylphosphine moiety onto the DPP 
core, hence quenching the inherently high fluorescence efficiency 
characteristic of diketopyrrolopyrroles (Figure 2).[38,39] Along those 
lines, we hypothesised that chemical oxidation of the 
triphenylphosphine moiety to its oxidised, triphenylphosphine 
oxide counterpart could preclude intramolecular PET and 
increase the fluorescence quantum yield of the probe. In addition, 
and importantly, this structural change would significantly reverse 
the type of non-covalent interactions in which the probe could 
engage with amino acids within the proteins of the inner 
mitochondrial membrane, hence potentially contributing to 
promoting preferential accumulation. 
Figure 2. Illustration of the proposed intramolecular photoinduced electron 
transfer quenching mechanism in PhDPP and turn-on effect in PhODPP upon 
oxidation, where DPP S1 and PhHOMO denote the frontier molecular orbitals of 
the DPP singlet excited state and HOMO energy levels of the 
phosphine/phosphine oxide moiety, respectively. 
To test this hypothesis in-silico, we went on to optimise the 
geometries of PhDPP and its oxidised counterpart, PhODPP by 
means of quantum mechanical calculations employing Thrular’s 
global-hybrid meta-GGA density functional M06-2X at the 6-31G* 
level. In agreement with the illustration in Figure 2, we observed 
a large decrease in the HOMO energy of the 
triphenylphosphine/triphenylphosphine oxide moiety upon 
oxidation (EHOMO(Ph) = -7.26 and -8.47 eV for the 
phosphine/phosphine oxide moiety in PhDPP and PhODPP 
respectively), which is consistent with our hypothesis that 
chemical oxidation of PhDPP would inhibit quenching and 
maximise fluorescence emission via a turn-on effect mechanism. 
Underpinned by these findings, PhODPP was synthesised 
following the previously described optimised method and could be 
readily separated from PhDPP via preparative chromatography. 
In all investigated solvents, both the absorption as well as 
fluorescence emission spectra of PhODPP exhibited negligible 
differences when compared to PhDPP spectra (Figure 1), which 
highlights that these properties are determined by the DPP moiety. 
As illustrated in Figure 3, the absorption spectra of PhODPP in all 
the investigated solvents were broad and displayed no vibronic 
structure. In turn, fluorescent emission spectral shape was 
irrespective of excitation wavelength (SI.2 ESI†) and exhibited 
vibronic progression, with the intensity of the 0-0 band being 
greater than that of the 0-1 band in all cases except water, where 
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the opposite relative orientation was observed, resulting in a 
significant bathochromic shift for PhODPP in water when 
compared to the spectra in the other investigated solvents (λem = 
550 and 599 nm in DMSO and water, respectively). 
Figure 3. Normalised absorption (solid line) and fluorescence emission (dashed 
line) spectra of PhODPP in acetonitrile (red), dichloromethane (yellow), DMSO 
(blue) and water (0.2% DMSO, green). 
In short, the latter can be ascribed to larger solvent induced 
planarity of the geometry of the relaxed first singlet excited state 
with respect to the optimised ground state, hence resulting in a 
greater relative displacement of the respective potential energy 
surfaces along the nuclear coordinates axis and the observed 
reversal of the relative intensity of the first two vibrational bands. 
Along these lines, similarly to the case of PhDPP, we report 
significant Stokes shift also for the oxidised probe (Δλmax = 2871 
and 4096 cm-1 for PhODPP in DMSO and water, respectively), 
which, again, minimises the probability of self-quenching, 
denoting a highly sought-after property in the realisation of novel 
fluorescent probes for bioimaging applications. 
 
Table 1. Absorption and fluorescence emission maxima (λmaxabs/em), Stokes 
shifts (Δλmax), fluorescence lifetimes (τf) and photoluminescence quantum 
yields (Φf) of PhDPP and PhODPP in acetonitrile (MeCN), dichloromethane 
(DCM), dimethyl sulfoxide (DMSO) and water (H2O). 
PhDPP λmaxabs/em / nm  Δλmax / cm-1 τf / ns Φf 
MeCN 471/556 3246 6.21 0.20±0.04 
DCM 476/539 2456 5.59 0.25±0.05 
DMSO 477/549 2749 5.87 0.23±0.06 
H2O[a] 481/604 4234 2.33 0.08±0.02 
PhODPP λmaxabs/em / nm  Δλmax / cm-1 τf / ns Φf 
MeCN 471/540 2713 6.38 0.88±0.05 
DCM 474/539 2544 6.24 >0.93 
DMSO 475/550 2871 6.38 >0.95 
H2O[a] 481/599 4096 3.62 0.56±0.05 
[a] 0.2% DMSO. 
 
Fluorescence lifetimes and quantum yields were also determined 
in all investigated solvents for PhODPP as well as for its non-
oxidised counterpart, PhDPP for comparison. Fluorescence 
lifetimes were observed to be comparable for both probes in the 
same solvent (e.g. τf = 6.21 and 6.38 ns for PhDPP and PhODPP 
in acetonitrile, respectively) and to furthermore be lower in water 
(τf = 2.33 and 3.62 ns for PhDPP and PhODPP, respectively). In 
contrast, and in line with our initial hypothesis and quantum 
mechanical calculations, a dramatic increase in fluorescence 
quantum yield was observed upon chemical oxidation (e.g. Φf = 
0.20±0.04 and 0.88±0.05 for PhDPP and PhODPP in acetonitrile, 
respectively). Remarkably, we report a 7-fold increase observed 
in fluorescence quantum yield in water on going from PhDPP to 
its oxidised counterpart (Φf = 0.08±0.02 and 0.56±0.05 for PhDPP 
and PhODPP, respectively), hence making the oxidised probe a 
potent fluorophore even in water. The even lower fluorescence 
quantum yield in water when compared to other investigated 
solvents for PhDPP, could be attributed to a more efficient PET in 
polar solvents. 
Motivated by these findings, we subsequently investigated the 
cellular uptake and organelle accumulation of PhODPP, with an 
aim to experimentally determine whether the structural changes 
would also result in preferential probe bioaccumulation within the 
mitochondria. 
 
Cell viability, cellular uptake and subcellular localisation of 
PhODPP 
Similarly to the case of PhDPP, we determined the cell viability of 
PhODPP for the human MCF7 breast cancer cells by the 
resazurin based metabolic assay PrestoBlue by treating the cells 
with PhODPP at concentrations ranging from 0.2 to 21.4 µg/mL 
(0.30 – 32 µM) and incubation for 1h. We report observed 
viabilities higher than 90% in all cases, consistent with no 
interference of the probe with the cell metabolism (Figure 4A).  
 
Figure 4. A MCF7 cell viability 1h incubation with serial dilutions (0.2 – 21.4 
µg/mL) of PhDPP (blue) and PhODPP (red), (n=3). B Flow cytometry histogram 
of human MCF7 breast cancer cells treated with different concentrations of 
PhDPP and PhODPP. λexc = 488 nm and λem =514-542 nm. 
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Next, we investigated the intracellular uptake and subcellular 
organelle localisation of PhODPP and compare these to the 
results observed for the non-oxidised counterpart, PhDPP. We 
report a significantly higher cell uptake for PhODPP when 
compared to PhDPP, as illustrated in Figure 4B. The latter can be 
ascribed to the observed increase in fluorescence emission 
efficiency (vide supra) but also to a better accumulation within the 
mitochondria as a result of the structural differences between 
triphenylphosphine and triphenylphosphine oxide. Importantly 
and contrary to the findings observed for PhDPP, PhODPP 
presented preferred co-localised organelle accumulation with the 
commercial mitochondria staining agent Mitotracker Red. 
Therefore, our oxidised probe, PhODPP, represents, to the best 
of our knowledge, the first report of a neutral DPP-based staining 
agent with preferential mitochondrial localisation and highlights 
the relevance that small chemical modifications can bear on 
subcellular organelle accumulation. In addition, the non-charged 
character of the developed probe would further alleviate common 
shortcomings in relation to probe-induced changes to the MMP, 
which denotes a critical point of concern in the development of 
novel systems for mitochondria imaging. 
Figure 5. A MCF7 intracellular distribution of PhODPP (250 nM, 0.163 μg/mL) and Mitotracker Red (250 nM, 0.133 μg/mL). Scale bar represents 50 μM. B 
Normalised absorption (dashed line) and fluorescence emission (solid line) spectra of PhODPP (top) and Mitotracker Red (bottom) in water (0.2% DMSO). Grey 
solid lines denote the excitation wavelengths (λexc = 488 and 561 nm for PhODPP and Mitotracker Red respectively) and grey bands illustrate spectral regions for 
PhODPP (λem = 500-526 and 614-620 nm for PhODPP and Mitotracker Red respectively). C Flow cytometry histogram of MCF7 cells treated with 250 nM 
concentrations of PhODPP and Mitotracker Red with λexc = 488 nm, spectral region λem = 500-526 nm (top) and λexc = 561 nm, spectral region λem = 614-620 nm 
(bottom). 
To further investigate and benchmark the use of PhODPP as a 
staining agent for mitochondria, we quantified its accumulation 
within this subcellular organelle and compared it to that of 
Mitotracker Red. Cell treatment was followed with 250 nM dosing 
of each probe at 10 min and 1h incubation times, as well as 
simultaneous 250 nM of both probes at 1h incubation. As 
illustrated in Figure 5 (A) and by means of flow cytometry (C), it 
was determined that PhODPP and Mitotrocker Red exhibit 
cumulative cell uptake with increasing exposure time and 
detectable levels after 10 min incubation in both cases (Figure 
5C). The working concentration of the developed system is at the 
nanomolar level and therefore lower than that required for other 
previously reported DPP-based bioimaging agents for 
mitochondria.[31–35] In this regard, although upon initial analysis of 
the flow cytometry histograms (Figure 5 C) reveal greater intensity 
for Mitotracker Red dosing when compared to our PhODPP probe, 
after careful evaluation, our results are consistent with 
comparable performance. In short, we ascribe the latter to the 
different extent to which the monitored spectral regions overlap 
with the emission spectra in each case (1.31 and 7.17 % for 
PhODPP and Mitotracker Red, respectively, Figure 5 B). Lastly, 
simultaneous dosing of the cells with both probes yielded a 
reduction of their fluorescence intensity signals, which was 
observed to be lower in the case of the commercial probe. 
Although a more in-depth investigation would be required, the 
larger decrease in the case of PhODPP could be attributed to an 
efficient resonance energy transfer process as a result of the large 
spectral overlap between the absorption spectrum of Mitotracker 
Red and the fluorescence emission spectrum of our synthesised 
probe. 
In summary, PhODPP denotes the first neutral DPP probe to 
exhibit mitochondrial accumulation (and one of the very few to do 
so irrespective of the chemistries exploited), performing at the 
nanomolar level, with comparable performance to the 
commercially available mitochondrial staining agent Mitotracker 
Red. In addition, PhODPP stock solutions in DMSO can be stored 
at 4-8 °C, whilst stock solution of Mitotracker Red must be stored 
at -20 °C, with stability compromised by the freeze and thaw cycle. 
Notably, PhODPP can also withstand the use of common cell 
preservatives (4% PFA), which is desirable for a variety of cell 
characterisation assays.  
Conclusions 
In conclusion, we report the design, synthesis, photophysical 
properties and comprehensive in-vitro characterisation of a novel 
diketopyrrolopyrrole phosphine oxide, denoting the first neutral 
DPP based system exhibiting preferred mitochondrial 
accumulation at the nanomolar level. Inspired by the ubiquitous 
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employment of delocalised lipophilic cations such as 
triphenylphosphonium to target mitochondria, we investigated 
whether a non-charged triphenylphosphine moiety anchored to a 
known fluorophore such as diketopyrrolopyrrole would still exhibit 
preference for that subcellular organelle. We observed relatively 
low cellular uptake and no preferential accumulation within our 
target organelle, which we ascribe to the inability of the 
triphenylphosphine moiety to engage in binding interactions with 
proteins within the mitochondrial inner membrane and to a lesser 
extent to its low fluorescence quantum yield as a result of efficient 
intramolecular photoinduced electron transfer. Underpinned by in-
silico approaches, we went on to synthesise a triphenylphosphine 
oxide analogue of our initial probe. We observed in line with our 
hypothesis, that PhODPP is a potent fluorophore as a result of 
chemical oxidation which precludes thermodynamically 
favourable intramolecular electron transfer. Cell viability studies 
using the human MCF7 breast cancer cell revealed no 
interference with the cell metabolism, with the phosphine oxide 
exhibiting a higher cell uptake when compared to our initial 
phopshine based attempt. Further, we report that this system 
demonstrates subcellular organelle colocalization with 
commercially available mitochondrial staining agent, Mitotracker 
Red at nanomolar concentrations. This system denotes the first 
report of a neutral diketopyrrolopyrrole-based fluorescent probe 
to selectively target mitochondria, therefore addressing known 
detrimental effects to the mitochondrial intermembrane potential 
associated with the use of charged molecular probes. Importantly, 
it is also the first DPP system, irrespective of the chemistries 
employed, to do so at nanomolar concentrations. Consequently, 
we anticipate this work to be of great relevance to those engaged 
in the development of mitochondrial bioimaging agents and more 
widely to those devoted to the realisation of superior fluorescent 
probes for bioimaging. 
Experimental Section 
Chemicals, reagents and instrumentation. NMR spectroscopy was 
carried out using a Bruker AV3 400 MHz instrument. FTIR spectroscopy 
was carried out by attenuated total reflectance using a Perkin Elmer, 
Spectrum One FTIR Spectrometer, with Universal ATR Sampling 
Accessory. Elemental analysis of Carbon, Hydrogen and Nitrogen (CHN) 
was carried out using a Perkin Elmer 2400 series 2 CHN analyser. Melting 
points were determined employing a Stuart SMP20 melting point 
apparatus. HPLC grade dichloromethane was purchased from Fisher-
Scientific and used as supplied. Spectroscopic grade dried-acetonitrile 
was purchased from Sigma-Aldrich and was distilled and stored over 3 Å 
molecular sieves (Sigma-Aldrich), which were oven dried before repeating 
the distillation process. Spectroscopy grade DMSO was purchased from 
Acros Organics and used as received. Steady-state absorption 
spectrophotometry measurements were performed using a Perkin-Elmer 
Lambda 40 UV-Vis spectrophotometer, operated by the software UV 
WinLab v.2.80.03 supplied by the manufacturer. Measurements were 
carried out in standard 10 mm match pair quartz cuvettes purchased from 
Hellma-Analytics. Steady-state fluorescence emission measurements 
were carried out employing a Perkin-Elmer LS50b luminescence 
spectrometer, controlled by means of the software FL WinLab v.4.00.03 
supplied by the manufacturer. The photomultiplier tube (R928, 
Hamamatsu) response was corrected using a file supplied by the 
manufacturer which accounts for its non-linear response. 10 mm precision 
quartz cuvettes purchased from Hellma-Analytics were used. In all cases, 
the optical density of the solutions was below 0.1. Fluorescence quantum 
yields were experimentally determined following a previously described 
method,[40] utilising an integrating sphere (Labsphere, 6’’ inner diameter). 
The samples were irradiated employing a Xe lamp (λexc = 469 nm) and the 
signal collected by an optical fibre coupled to Maya2000Pro UV-NIR 
spectrometer. Lifetime measurements were carried out by using a time-
correlated single-photon-counting instrument (Edinburgh Instruments FLS 
920). To excite the samples a picosecond-pulsed EPLED 485 (482.0 nm, 
pulse width FWHM: 100.6 ps) was used. Deconvolution analysis of the 
decay kinetics yielded the fluorescence lifetimes. A light-scattering Ludox 
solution was used to obtain the instrument response function.   
Synthesis and characterisation of 2,5-Dibenzyl-3-[4-
(diphenylphosphoryl)phenyl]-6-phenylpyrrolo[3,4-c]pyrrole-1,4-
dione (PhODPP). A solution of 2,5-Dibenzyl-3-(4-iodophenyl)-6-
diphenylpyrrolo[3,4-c]pyrrole-1,4-dione (0.300 g, 0.500 mmol), 
triphenylphosphine (0.800 g, 3.05 mmol) and palladium(II) acetate (0.028 
g, 0.125 mmol, 25 mol%) in anhydrous dimethylformamide (36 mL) was 
heated to 110–120 °C and stirred for 18 hours. The solution was 
concentrated under reduced pressure to give a dark red oil, which was 
purified by flash column chromatography eluting in dichloromethane/ethyl 
acetate (1:1). The product was then suspended in methanol and slowly 
precipitated overnight. After a second column of the filtered product, 
eluting in dichloromethane/ethyl acetate (1:1), it was precipitated in 
dichloromethane/hexane before being dried overnight under vacuum to 
give a fluorescent orange powder (0.140 g, 42 % yield). 1H NMR (CDCl3, 
400 MHz) δ (ppm): 4.98 (s, 2H, CH2), 4.99 (s, 2H, CH2), 7.14-7.21 (m, 4H, 
ArH), 7.21-7.34 (m, 6H, ArH), 7.42-7.53 (m, 7H, ArH), 7.53-7.61 (m, 2H, 
ArH), 7.63-7.80 (m, 8H, ArH), 7.81-7.87 (m, 2H, ArH). 13C NMR (CDCl3, 
100 MHz) δ (ppm): 45.76 (CH2), 109.60 (C), 110.63 (C), 126.63 (CH), 
127.47 (CH), 127.61 (C), 128.63 (CH, d, 3JCP=12.33 Hz), 128.72 (C), 
128.82 (CH), 128.92 (CH), 129.07 (CH), 131.06 (C, d, 4JCP=3.08 Hz), 
131.21 (C), 131.69 (CH), 132.05 (CH, d, 2JCP=10.02 Hz), 132.19 (CH, d, 
4JCP=2.31 Hz), 132.41 (CH, d, 2JCP=10.02 Hz), 135.81 (C, d, 1JCP=101.72 
Hz), 137.13 (C), 137.20 (C), 147.15 (C), 150.09 (C), 162.48 (C=O), 162.71 
(C=O). 31P NMR (CDCl3, 162 MHz) δ (ppm): 28.34. IR (ATR)/cm−1: 3057 
(ArH), 3026 (ArH), 2962 (CH2), 1668 (C=O), 1615 (C=C), 1590 (C=C), 
1494 (C=C), 1452 (C=C), 1379 (CH2), 1345 (CH2), 1184 (P=O), 1115 (C-
H), 717 (ArH), 690 (ArH). Anal. Calculated for C44H33N2O3P: C (79.03), H 
(4.97), N (4.19). Found: C (78.06), H (4.99), N (4.17). Melting point: 196–
198 °C. 
Synthesis and characterisation of 2,5-Dibenzyl-3-[4-
(diphenylphosphanyl)phenyl]-6-phenylpyrrolo[3,4-c]pyrrole-1,4-
dione (PhDPP). A solution of 2,5-Dibenzyl-3-(4-iodophenyl)-6-
diphenylpyrrolo[3,4-c]pyrrole-1,4-dione (3.15 g, 5.30 mmol), 
triphenylphosphine (8.37 g, 31.9 mmol) and palladium(II) acetate (0.305 g, 
1.35 mmol, 25 mol%) in anhydrous dimethylformamide (380 mL) was 
heated to 110–120 °C and stirred for 18 hours. The solution was 
concentrated under reduced pressure to give a dark red oil, which was 
purified by flash column chromatography eluting in dichloromethane/ethyl 
acetate (9:1). The product was then further purified by a second flash 
column, eluting in hexane/dichloromethane (1:2), before being 
concentrated and dried overnight under vacuum to give a fine orange 
powder (0.450 g, 13 % yield). 1H NMR (CDCl3, 400 MHz) δ (ppm): 5.00 (s, 
2H, CH2), 5.01 (s, 2H, CH2), 7.16-7.22 (m, 4H, ArH), 7.22-7.40 (m, 17H, 
ArH), 7.42-7.52 (m, 4H, ArH), 7.72-7.80 (m, 4H, ArH). 13C NMR (CDCl3, 
100 MHz) δ (ppm): 45.60 (CH2), 109.68 (C), 109.84 (C), 126.65 (CH, d, 
3JCP=7.71 Hz), 126.69 (C, d, 4JCP=6.94 Hz), 127.35, 127.68, 127.81, 
128.67 (CH, d, 4JCP=6.94 Hz), 128.76, 128.85, 129.04, 129.14, 131.42, 
133.47 (CH, d, 2JCP=19.27 Hz), 134.00 (CH, d, 2JCP=20.04 Hz), 136.04 (C, 
d, 1JCP=10.79 Hz), 137.35 (C, d, 1JCP=10.02 Hz), 142.36, 142.50, 148.41, 
149.07, 162.67 (C=O), 162.72 (C=O). 31P NMR (CDCl3, 162 MHz) δ (ppm): 
−4.37. IR (ATR)/cm−1: 3057 (ArH), 3029 (ArH), 2921 (CH2), 1677 (C=O), 
1608 (C=C), 1591 (C=C), 1495 (C=C), 1422 (C=C), 1384 (CH2), 1358 
(CH2), 1121 (C-H), 722 (ArH), 692 (ArH). Anal. Calculated for 
C44H33N2O2P: C (80.96), H (5.10), N (4.29). Found: C (79.66), H (5.04), N 
(4.13). Melting point: 229–232 °C. 
Computational details. The ground state geometries of PhDPP and 
PhODPP were optimised by means of the density functional M06-2X[41] at 
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the 6-31G(d) level as implemented in Spartan 10 package.[42] In both cases, 
energy optimised geometries were confirmed by IR analysis, which were 
characterised by the absence of any imaginary modes, thus consistent 
with real equilibrium minima.[43–45] The cartesian coordinates for the 
optimised geometries of both probes can be found in the associated 
supporting information (SI.4 ESI†). 
Cell culture and in-vitro imaging. Stock solutions of both PhDPP and 
PhODPP were prepared in DMSO for all cell-based experiments, which 
were used in all cases at DMSO concentrations lower than 0.5% (v/v). Cell 
culture was performed utilising human MCF7 breast cancer cell line, 
maintained in high glucose Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% foetal bovine serum (FBS), 1% L-glutamine (200 
mM) and 1% antibiotic solution (100 U penicillin/0.1 mg/L streptomycin, all 
purchased from Sigma-Aldrich. Cells were sub-cultured in appropriate 
plates/dishes at 15,625 cells/cm2 in phenol red free DMEM without 
antibiotics and were allowed to rest for 24h before being used for 
experiments. In all cases, cells were incubated at 37 °C and 5% CO2 
humidified atmosphere. Flow cytometry data was acquired to quantify the 
cell uptake of PhDPP, PhODPP as well as commercially available staining 
agent, Mitotracker Red CMXRos (Life Technologies). Cells were sub-
cultured in 6-well plates and treated with different probes (vide infra), 
thoroughly washed with warm phosphate buffer saline (PBS), detached 
using trypsin-EDTA (Sigma Aldrich) and resuspended in 500 μL of 4% 
paraformaldehyde in sterile PBS. Quantitative measurements of DPP 
uptake were assessed following cell treatment with PhDPP (1.0 and 5.0 
μg/mL) and PhODPP (0.5, 1.0 and 5.0 μg/mL), which were incubated for 
1h. Cytometry data of DPP uptake was detected in a FC500 (Beckman 
Coulter, λexc = 488 nm and λem = 514-542 nm). The quantification of 
mitochondrial accumulation of PhODPP and commercially available 
Mitotracker Red CMXRos was performed following cell treatment with 250 
nM of each probe, at 10 min and 1 h incubation times, as well as 
simultaneous treatment with 250 nM of both probes (1h incubation) 
Cytometry data for PhODPP and Mitotracker Red CMXRos was acquired 
in an Astrios cell sorter (Beckman Coulter, λexc = 488 nm and λem = 500-
526 nm for PhODPP and λexc = 561 nm and λem = 604-624 nm for 
Mitotracker Red CMXRos). Acquired flow cytometry data was then 
analysed using Kaluza software provided by the manufacturer. The 
median fluorescence intensity values of homogeneous and healthy cell 
populations (% Gated) was used to quantify the cell uptake. Confocal 
microscopy analyses were carried out in cells that were sub-cultured in 
glass dishes (CELLviewTM culture dish, Greiner Bio-One, Germany), that 
received the appropriate treatment (vide infra) and that were incubated 
with Hoechst 33342 at 5 μg/mL for 10 min in all cases. Cells were then 
thoroughly washed with warm PBS and preserved with 4% 
paraformaldehyde in sterile PBS. The visualisation of intracellular probe 
accumulation was performed in a TCS SPE Leica confocal microscope 
using a 40x objective. Obtained images were then analysed using ImageJ 
software (Rasband). To characterise the cell uptake, cells were incubated 
with 1 μg/mL PhDPP/PhODPP in DMSO and 250 nM Mitotracker Red 
CMXRos for 1h. To further characterise the PhODPP mitochondrial 
accumulation, the cells were treated with 250 nM of PhODPP and 
Mitotracker Red CMXRos for 1h. The cell viability of PhDPP and PhODPP 
was determined by the resazurin based metabolic assay PrestBlueTM 
(Thermofisher Scientific) at three different passage numbers. After 24h of 
cell sub-culture in black 96-well plates (NunclonTM Delta surface, Thermo 
Scientific), cells were treated with serial dilutions of PhDPP and PhODPP 
in DMSO 0.17-21.38 µg/mL(32 μM -250 nM), vehicle control (DMSO 0.02-
2% v/v), positive control (TritonX 1%) and negative control (cell culture 
media). Cells were incubated for 1h after treatment, then washed with 
warm PBS three times and incubated for 1h with prestoBlueTM in cell 
culture media (ratio 1:9 (v/v), 100 μL/well). Lastly, the luminescence (λexc 
= 560 nm and λem = 600 nm) was subsequently detected in a TECAN 
microplate reader (Tecan Trading AG, Switzerland). 
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Selective mitochondrial imaging by a neutral probe at the nanomolar level is 
demonstrated employing a rationally designed triphenylphosphine oxide-bearing 
diketopyrrolopyrrole. 
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